Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Prevalence of symptomatic androgen deficiency in men.

Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB.

J Clin Endocrinol Metab. 2007 Nov;92(11):4241-7. Epub 2007 Aug 14.

PMID:
17698901
[PubMed - indexed for MEDLINE]
2.

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM; Task Force, Endocrine Society.

J Clin Endocrinol Metab. 2010 Jun;95(6):2536-59. doi: 10.1210/jc.2009-2354. Review.

PMID:
20525905
[PubMed - indexed for MEDLINE]
3.

[Contribution of bioavailable testosterone assay for the diagnosis of androgen deficiency in elderly men].

Lejeune H, D├ęchaud H, Pugeat M.

Ann Endocrinol (Paris). 2003 Apr;64(2):117-25. Review. French.

PMID:
12773947
[PubMed - indexed for MEDLINE]
4.

Defining 'relative' androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health?

Haren MT, Morley JE, Chapman IM, O'Loughlin PD, Wittert GA.

Climacteric. 2002 Mar;5(1):15-25. Review.

PMID:
11974555
[PubMed - indexed for MEDLINE]
5.

Testosterone supplementation therapy for older men: potential benefits and risks.

Gruenewald DA, Matsumoto AM.

J Am Geriatr Soc. 2003 Jan;51(1):101-15; discussion 115. Review.

PMID:
12534854
[PubMed - indexed for MEDLINE]
6.

The decline of androgen levels in elderly men and its clinical and therapeutic implications.

Kaufman JM, Vermeulen A.

Endocr Rev. 2005 Oct;26(6):833-76. Epub 2005 May 18. Review.

PMID:
15901667
[PubMed - indexed for MEDLINE]
7.

Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy.

Buvat J, Lemaire A.

J Urol. 1997 Nov;158(5):1764-7. Review.

PMID:
9334596
[PubMed - indexed for MEDLINE]
8.

Testosterone and ill-health in aging men.

Yeap BB.

Nat Clin Pract Endocrinol Metab. 2009 Feb;5(2):113-21. doi: 10.1038/ncpendmet1050. Review.

PMID:
19165223
[PubMed - indexed for MEDLINE]
9.

[PADAM from the urologic viewpoint].

Ludwig G.

Urologe A. 2000 Sep;39(5):407-10. Review. German.

PMID:
11045038
[PubMed - indexed for MEDLINE]
10.

11: Androgen deficiency and replacement therapy in men.

Handelsman DJ, Zajac JD.

Med J Aust. 2004 May 17;180(10):529-35. Review.

PMID:
15139833
[PubMed - indexed for MEDLINE]
11.

Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations.

Liu PY, Swerdloff RS, Veldhuis JD.

J Clin Endocrinol Metab. 2004 Oct;89(10):4789-96. Review.

PMID:
15472164
[PubMed - indexed for MEDLINE]
12.

Defining the prevalence and incidence of androgen deficiency in aging men: where are the goal posts?

McLachlan RI, Allan CA.

J Clin Endocrinol Metab. 2004 Dec;89(12):5916-9. Review. No abstract available.

PMID:
15579736
[PubMed - indexed for MEDLINE]
13.

Female androgen deficiency syndrome--an unproven hypothesis.

Bhasin S.

J Clin Endocrinol Metab. 2005 Aug;90(8):4970-2. Review. No abstract available.

PMID:
16087958
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk